主要和次要转移性传播:多种途径导致与癌症有关的死亡
D Sparrer1,2, R Blazquez3, F Keil4
1Center for Translational Oncology, University Hospital Regensburg, Regensburg, 93053, Germany.
Molecular cancer
|July 22, 2025
概括
转移性癌症导致大多数癌症死亡,往往导致器官衰竭. 了解特定器官的传播和破坏是开发新疗法的关键,以保持器官功能.
科学领域:
- 在瘤学瘤学.
- 病理生理学 病理生理学
- 癌症转移 癌症转移
背景情况:
- 转移性疾病导致大约80%的癌症相关死亡.
- 器官衰竭,通常是由于腹部,心血管,神经或呼吸道并发症,是死亡的主要原因.
- 目前对特定器官的转移途径和组织破坏机制的理解仍然有限.
研究的目的:
- 提高对特定器官的转移性传播和破坏的理解.
- 阐明二次和随后的转移性波的病理生理学.
- 突出在癌症治疗中维持器官功能的新兴治疗目标.
主要方法:
- 文献综述和对转移性生物学当前研究的综合.
- 分析与转移性疾病进展和器官衰竭相关的临床数据.
- 开发一种概念模型,使转移性生物学与临床护理目标保持一致.
主要成果:
- 区分初级转移性传播与二次器官内传播至关重要.
- 了解特定器官的破坏过程对于推进患者护理至关重要.
- 癌症护理模型的生物治疗目标集成了转移生物学,临床阶段和治疗指示.
结论:
- 维持器官功能是癌症护理中一个新兴的关键治疗目标.
- 阐明转移性波的病理生理学对于开发有效的治疗方法至关重要.
- 癌症护理模型的生物治疗目标为调整研究和临床实践提供了一个框架.
相关概念视频
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Cancer Cell Migration through Invadopodia
2.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K


